On October 2, 2020, the Association of American Physicians and Surgeons (AAPS) stated in a post on their website:
The number of studies on hydroxychloroquine (HCQ) has reached 126, with 76 peer-reviewed. The evidence overwhelmingly shows that early treatment is likely to be effective, while late treatment is much less likely to help. Early treatment is also likely to reduce the period of infectiousness.
Thousands of physicians worldwide are using HCQ with zinc and azithromycin or doxycycline, and are reporting excellent results. Nations where HCQ is widely and freely used have a death rate 73 percent lower than nations such as the U.S. in which its use is discouraged or restricted.
Adequate levels of vitamin D and zinc are critical for resisting viral infections, notes AAPS. A number of other treatments including ivermectin and corticosteroids are also showing great promise.
HCQ in an appropriate dose is one of the world’s safest medicines, safer than most drugs available over the counter, AAPS points out, as shown by more than 65 years of use in hundreds of millions of patients.https://aapsonline.org/aaps-urges-president-and-first-lady-to-protect-nation-with-early-treatment-for-covid-19/
This represents AAPS’ long history of supporting and defending medical ethics, and putting patients first. In 1990, they adopted the Patients’ Freedoms to guide their work.